← Leaderboards
Bin Gu
Michigan State University
$1,604,042
Attributed
$1,604,042
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $673.3K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,604,042 · 3
By mechanism
R37$1,293,764 · 1
R03$310,278 · 2
Top collaborators
No co-investigators on record.
Most similar at Michigan State University
Same institution · by research overlap
- Stephanie W Watts$13,942,842
- Michelle M Martel$6,088,423
- Chiho Sugimoto$62,840
- Gina Marie Leinninger$5,975,543
Others in their field
Other Rising Stars on “Oncogenic”
- Timothy O'Connor · Rockefeller University$7,019,416
- Alexander Federation · Talus Bioscience, Inc.$4,098,558
- Jens Eickhoff · University Of Wisconsin-Madison$3,606,160
- Xu Chen · University Of California, San Francisco$3,581,285
- John D Gordan · University Of California, San Francisco$2,669,851
- Ricardo Mouro Pinto · Massachusetts General Hospital$2,559,051
Research focus
OncogenicEctopic ExpressionGenetically Engineered MouseGenesTissuesCellsTestisMalignant NeoplasmsChromosomal TranslocationFusion GeneTumorEffective TherapyNut CarcinomaMouse ModelMutationTargeted TreatmentGenomicsProteinsSide EffectIn VivoCell LineCell TypeAnimal ModelNuclear Protein
Grant awards (6)
Developing a clinically-relevant genetically engineered mouse model for Nut carcinoma$441,475
R37 · FY2025 · CA · contact PI
Developing a Dre-rox Recombination-Based Genetically Engineered Mouse Model (GEMM) for NUT Carcinoma$153,278
R03 · FY2025 · CA · contact PI
Developing humanized Nut Carcinoma mouse model for developing NUTM1 targeted therapies.$78,500
R03 · FY2025 · CA · contact PI
Developing a clinically-relevant genetically engineered mouse model for Nut carcinoma$418,571
R37 · FY2024 · CA · contact PI
Developing humanized Nut Carcinoma mouse model for developing NUTM1 targeted therapies.$78,500
R03 · FY2024 · CA · contact PI
Developing a clinically-relevant genetically engineered mouse model for Nut carcinoma$433,718
R37 · FY2023 · CA · contact PI